49 results on '"Singal, Amit G."'
Search Results
2. The Authors’ Reply
3. Racial and Ethnic Disparities in Liver Transplantation for Alcohol-associated Liver Diseases in the United States
4. Racial and Ethnic Disparities in Liver Transplantation for Alcohol-associated Liver Diseases in the United States
5. The Practice of Retransplantation for Recurrent Alcohol-associated Liver Disease in the United States Is Uncommon With Acceptable Outcomes
6. Prognostic Value of Hypochloremia in Critically Ill Patients With Decompensated Cirrhosis
7. Stereotactic ablative radiotherapy for hepatocellular carcinoma: History, current status, and opportunities
8. Issue Highlights
9. Effect of hospital safety net designation on treatment use and survival in hepatocellular carcinoma
10. Overdiagnosis: An Understudied Issue in Hepatocellular Carcinoma Surveillance
11. Cost effectiveness of regorafenib as second‐line therapy for patients with advanced hepatocellular carcinoma
12. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial
13. Direct‐acting antivirals and recurrence of hepatocellular carcinoma
14. Reply
15. Cost-Effectiveness of Risk Score–Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis
16. Tumor Enhancement and Heterogeneity Are Associated With Treatment Response to Drug-Eluting Bead Chemoembolization for Hepatocellular Carcinoma
17. Patient‐reported barriers are associated with lower hepatocellular carcinoma surveillance rates in patients with cirrhosis
18. FIB-4 and imaging for measuring fibrosis in hepatitis C virus
19. Outcomes of Simultaneous Liver Kidney Transplantation in Patients With Hepatocellular Carcinoma
20. Survival and cost‐effectiveness of sorafenib therapy in advanced hepatocellular carcinoma: An analysis of the SEER–Medicare database
21. Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis
22. Body Composition Features Predict Overall Survival in Patients With Hepatocellular Carcinoma
23. Development of the Parkland-UT Southwestern Colonoscopy Reporting System (CoRS) for evidence-based colon cancer surveillance recommendations
24. A Variant in PNPLA3 Associated With Fibrosis Progression but not Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection
25. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system
26. Treatment of Liver Cancer
27. Liver Cancer
28. Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice
29. Downstaging hepatocellular carcinoma: A systematic review and pooled analysis
30. Spirochetes as an Almost Forgotten Cause of Hepatitis
31. Clinical Reminders for Hepatocellular Carcinoma Surveillance: An Early Step in a Long Journey
32. Accuracy of α-Fetoprotein Measurement in Detection of Hepatocellular Carcinoma—1 More Nail in the Coffin
33. Lactulose vs Polyethylene Glycol 3350-Electrolyte Solution for Treatment of Overt Hepatic Encephalopathy: The HELP Randomized Clinical Trial
34. Factors That Affect Accuracy of α-Fetoprotein Test in Detection of Hepatocellular Carcinoma in Patients With Cirrhosis
35. A Primer on Predictive Models
36. A Primer on Effectiveness and Efficacy Trials
37. Surveillance for Hepatocellular Carcinoma: How Can We Do Better?
38. Practice Patterns and Attitudes of Primary Care Providers and Barriers to Surveillance of Hepatocellular Carcinoma in Patients With Cirrhosis
39. Importance of Determining Indication for Colonoscopy: Implications for Practice and Policy
40. Improving Hepatocellular Carcinoma Screening: Applying Lessons From Colorectal Cancer Screening
41. Improving Screening for Hepatocellular Carcinoma by Incorporating Data on Levels of α-Fetoprotein, Over Time
42. A potential novel use for direct antiviral therapy
43. Presentation, Treatment, and Clinical Outcomes of Patients With Hepatocellular Carcinoma, With and Without Human Immunodeficiency Virus Infection
44. Regression of Hepatocellular Carcinoma With Right Atrial Extension After Sorafenib and Transarterial Chemoembolization
45. Interferon Therapy and Prevention of Hepatocellular Carcinoma in Hepatitis C
46. Predictors of Liver Transplant Eligibility for Patients with Hepatocellular Carcinoma in a Safety Net Hospital
47. Detection and management of latent tuberculosis in liver transplant patients
48. An Automated Model Using Electronic Medical Record Data Identifies Patients With Cirrhosis at High Risk for Readmission
49. A Sustained Viral Response Is Associated With Reduced Liver-Related Morbidity and Mortality in Patients With Hepatitis C Virus
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.